Immunizations in the United States: Success, structure, and stress

被引:59
作者
Orenstein, WA [1 ]
Douglas, RG
Rodewald, LE
Hinman, AR
机构
[1] Emory Univ, Program Vaccine Policy & Dev, Atlanta, GA USA
[2] Emory Univ, Vaccine Ctr, Atlanta, GA USA
[3] US Ctr Dis Control & Prevent, Serv Div, Natl Immunizat Program, Atlanta, GA USA
[4] Publ Hlth Informat Inst, Task Force Child Survival & Dev, Decatur, GA USA
关键词
D O I
10.1377/hlthaff.24.3.599
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Immunization is a great success of preventive medicine. In the United States, most vaccine-preventable diseases of childhood are at or near record lows while the number of diseases preventable by vaccination has increased. These successes result from a comprehensive system that includes basic research; developing and testing vaccine candidates; a manufacturing base; a regulatory authority; development of immunization policies; implementation of immunization recommendations; and a compensation system for the few people unavoidably injured by vaccines. Despite the successes, the system faces numerous challenges, including vaccine supply, cost, and safety; adult immunization; vaccine research and development; and biopreparedness.
引用
收藏
页码:599 / 610
页数:12
相关论文
共 37 条
[1]  
Bartlett D. L., 2004, Morbidity and Mortality Weekly Report, V53, P431
[2]  
BAYLOR NW, 2004, VACCINES, P1539
[3]  
*CDC, 2005, CDC VACC PRIC LIST
[4]  
*CDC, 2003, VACC CHILDR VACC SUP
[5]  
*CDC, 2003, NAT IMM SURV LIST TA
[6]   Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States [J].
Chen, RT ;
Glasser, JW ;
Rhodes, PH ;
Davis, RL ;
Barlow, WE ;
Thompson, RS ;
Mullooly, JP ;
Black, SB ;
Shinefield, HR ;
Vadheim, CM ;
Marcy, SM ;
Ward, JI ;
Wise, RP ;
Wassilak, SG ;
Hadler, SC ;
Swint, E ;
Hardy, JR ;
Payne, T ;
Immanuel, V ;
Benson, P ;
Draket, J ;
Drew, L ;
Mendius, B ;
Ray, P ;
Lewis, N ;
Fireman, BH ;
Jing, J ;
Wulfsohn, M ;
Lugg, MM ;
Osborne, P ;
Rastogi, S ;
Patriarca, P ;
Caserta, V .
PEDIATRICS, 1997, 99 (06) :765-773
[7]  
CHEN RT, VACCINES, P1557
[8]   Priorities among recommended clinical preventive services [J].
Coffield, AB ;
Maciosek, MV ;
McGinnis, JM ;
Harris, JR ;
Caldwell, MB ;
Teutsch, SM ;
Atkins, D ;
Richland, JH ;
Haddix, A .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 21 (01) :1-9
[9]   The price of innovation: new estimates of drug development costs [J].
DiMasi, JA ;
Hansen, RW ;
Grabowski, HG .
JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185
[10]  
DOUGLAS GD, VACCINES, P47